85 related articles for article (PubMed ID: 1472918)
1. Generation and properties of neutrophil-activating peptide 2.
Walz A
Cytokines; 1992; 4():77-95. PubMed ID: 1472918
[No Abstract] [Full Text] [Related]
2. Structural requirements of platelet chemokines for neutrophil activation.
Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
[TBL] [Abstract][Full Text] [Related]
3. The neutrophil-activating peptide 1/interleukin 8, a novel neutrophil chemotactic cytokine.
Schröder JM
Arch Immunol Ther Exp (Warsz); 1992; 40(1):23-31. PubMed ID: 1485824
[No Abstract] [Full Text] [Related]
4. Formation and biological properties of neutrophil activating peptide 2 (NAP-2).
Walz A; Zwahlen R; Baggiolini M
Adv Exp Med Biol; 1991; 305():39-46. PubMed ID: 1755378
[No Abstract] [Full Text] [Related]
5. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors.
Zipfel PF; Balke J; Irving SG; Kelly K; Siebenlist U
J Immunol; 1989 Mar; 142(5):1582-90. PubMed ID: 2521882
[TBL] [Abstract][Full Text] [Related]
7. [Naf/nap-1, a new peptide which activates neutrophil leukocytes].
Baggiolini M; Walz A
Schweiz Med Wochenschr; 1989 Sep; 119(38):1285-9. PubMed ID: 2686005
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing.
Yan Z; Holt JC; Stewart GJ; Niewiarowski S
Am J Physiol; 1993 Nov; 265(5 Pt 1):C1396-404. PubMed ID: 8238487
[TBL] [Abstract][Full Text] [Related]
9. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.
Clark-Lewis I; Dewald B; Geiser T; Moser B; Baggiolini M
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3574-7. PubMed ID: 8475106
[TBL] [Abstract][Full Text] [Related]
10. Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty.
Bunescu A; Widman J; Lenkei R; Menyes P; Levin K; Egberg N
Clin Sci (Lond); 2002 Mar; 102(3):279-86. PubMed ID: 11869168
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-activating polypeptides IL-8 and NAP-2 induce identical signal transduction pathways in the regulation of lysosomal enzyme release.
Petersen F; Van Damme J; Flad HD; Brandt E
Lymphokine Cytokine Res; 1991 Apr; 10(1-2):35-41. PubMed ID: 1651769
[TBL] [Abstract][Full Text] [Related]
12. Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor.
Thomas KM; Taylor L; Prado G; Romero J; Moser B; Car B; Walz A; Baggiolini M; Navarro J
J Immunol; 1994 Mar; 152(5):2496-500. PubMed ID: 8133060
[TBL] [Abstract][Full Text] [Related]
13. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
14. Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils.
Hayashi S; Kurdowska A; Miller EJ; Albright ME; Girten BE; Cohen AB
J Immunol; 1995 Jan; 154(2):814-24. PubMed ID: 7814885
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1.
Furie B; Furie BC
Thromb Haemost; 1995 Jul; 74(1):224-7. PubMed ID: 8578462
[No Abstract] [Full Text] [Related]
16. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
Härter L; Petersen F; Flad HD; Brandt E
J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
[TBL] [Abstract][Full Text] [Related]
18. Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
Van Osselaer N; Van Damme J; Rampart M; Herman AG
Am J Pathol; 1991 Jan; 138(1):23-7. PubMed ID: 1824807
[TBL] [Abstract][Full Text] [Related]
19. Two burgeoning families of platelet factor 4-related proteins: mediators of the inflammatory response.
Stoeckle MY; Barker KA
New Biol; 1990 Apr; 2(4):313-23. PubMed ID: 2149646
[TBL] [Abstract][Full Text] [Related]
20. Generation of NAP-1 and related peptides in psoriasis and other inflammatory skin diseases.
Schröder JM
Cytokines; 1992; 4():54-76. PubMed ID: 1472917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
